These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 28272974)

  • 1. Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy.
    Romanò L; Galli C; Tagliacarne C; Tosti ME; Velati C; Fomiatti L; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zotti CM; Mele A; Zanetti AR;
    Hum Vaccin Immunother; 2017 May; 13(5):981-985. PubMed ID: 28272974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study.
    Spada E; Romanò L; Tosti ME; Zuccaro O; Paladini S; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti CM; Mele A; Zanetti AR;
    Clin Microbiol Infect; 2014 Oct; 20(10):O680-6. PubMed ID: 24528380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Gabbuti A; Romanò L; Blanc P; Meacci F; Amendola A; Mele A; Mazzotta F; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3129-32. PubMed ID: 17291637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination.
    Teoharov P; Kevorkyan A; Petrova N; Baltadzhiev I; Van Damme P
    Pediatr Infect Dis J; 2013 Jan; 32(1):51-3. PubMed ID: 22914584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy.
    Bagheri-Jamebozorgi M; Keshavarz J; Nemati M; Mohammadi-Hossainabad S; Rezayati MT; Nejad-Ghaderi M; Jamalizadeh A; Shokri F; Jafarzadeh A
    Hum Vaccin Immunother; 2014; 10(12):3731-6. PubMed ID: 25483689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Persistence of immune memory and its related factors at 12 years after hepatitis B vaccination among adults].
    Zhang L; Yan BY; Lyu JJ; Liu JY; Kong Q; Wu WL; Feng Y; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 May; 53(5):497-502. PubMed ID: 31091608
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B
    Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
    Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
    Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy.
    Dini G; Toletone A; Barberis I; Debarbieri N; Massa E; Paganino C; Bersi F; Montecucco A; Alicino C; Durando P
    Hum Vaccin Immunother; 2017 Feb; 13(2):440-444. PubMed ID: 27925503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.